Table 2 from Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors
Authors:
- Apostolia M. TsimberidouApostolia M. Tsimberidou
- David J. ViningDavid J. Vining
- Sukeshi P. AroraSukeshi P. Arora
- Sofia de AchavalSASofia de Achaval
- Jeffrey LarsonJLJeffrey Larson
- John KauhJKJohn Kauh
- Carrie CartwrightCCCarrie Cartwright
- Rony AvritscherRony Avritscher
- Imran AlibhaiIAImran Alibhai
- David J. TweardyDavid J. Tweardy
- Ahmed O. KasebAhmed O. Kaseb
Open Access
- 17 March 2025
- other
- Published by American Association for Cancer Research (AACR)